Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지

EXPRESSION OF DOMINANT NEGATIVE p63 ISOFORM IN WELL-DIFFERENCIATED ORAL SQUAMOUS CELL CARCINOMA

분화도 좋은 구강 편평상피세포암종에서 Dominant Negative p63 isoform의 발현

  • Kim, In-Su (Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University) ;
  • Kim, Chul-Hwan (Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University) ;
  • Kim, Kyung-Wook (Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University)
  • 김인수 (단국대학교 치과대학 구강외과학교실) ;
  • 김철환 (단국대학교 치과대학 구강외과학교실) ;
  • 김경욱 (단국대학교 치과대학 구강외과학교실)
  • Published : 2007.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

The p53 which is well known as tumor suppressor gene is located at 17p13. p53 is a sequence-specific DNA binding transcription factor that responds to certain cytotoxic stresses, such as DNA damage, by enhancing the transcription of genes that regulate cell-cycle progression as well as programmed cell death. The p63 gene that is located at 3q27-29, is recognized members of the p53 family, and responsible for the transcription of 6 isoforms. Three isoforms ($TAp63{\alpha}$, $TAp63{\beta}$, $TAp63{\gamma}$) contain an N-terminal transactivation (TA) domain and can induce apoptosis. The other 3 isoforms (${\Delta}Np63{\alpha}$, ${\Delta}Np63{\beta}$, ${\Delta}Np63{\gamma}$) lack the TA domain and may function in a dominant-negative fashion by inhibiting the transactivation functions of p53 and TAp63 proteins, and thus act as oncoproteins. A number of studies have investigated the role of p63 in human squamous cell carcinomas from different organs. Only a few studies have examined ${\Delta}Np63$ isoform in oral squamous cell carcinoma including normal epithelium. This study aimed to evaluate expression of ${\Delta}Np63$ isoform in human oral squamous cell carcinoma tissue and normal mucosa. The 3 cases of well differenciated oral squamous cell carcinoma specimen including adjacent normal mucosa were examined, and immunohistochemical study with monoclonal antibody(4A4) and tumor cell apoptosis analysis with Transmission Electon Microscopy were studied. And, RT-PCR analysis was done for expression of ${\Delta}Np63$ isoform. The results were as followed. 1. Normal gingiva showed the restricted p63 expression in basal cell layer. 2. Well differentiated squamous cell carcinoma showed mainly p63 expression in overall area of malignancy, especially in basal cell layer to adjacent stromal tissue. 3. Tumor cells around keratinized area with no p63 expression disclosed less micro-organelle in decreased size cytoplasm and severe chromatin margination with nuclear destruction that means apoptosis. 4. Comparison of mRNA expression of ${\Delta}Np63$ isoform by RT-PCR showed variable expression of ${\Delta}Np63$ isoform, but ${\Delta}Np63{\alpha}$ was most highly expressed in all 3 tumor specimen. From theses results, it should be suggested that ${\Delta}Np63$ isoform expression in well differentiated squamous cell carcinoma was closely related to tumor oncogenesis, expecially overexpression of ${\Delta}Np63{\alpha}$ is a most important factor in tumor genesis of oral squamous cell carcinoma.

Keywords

References

  1. Bishop JM: Viral oncogenes. Cell 1985;42:23
  2. Hayward JR, Regezi JA: Oral dysplasia and in situ carcinoma: Clinicopathologic correlation of eight patients. J Oral Surg 1977; 35:756-762
  3. Donehower LA, Harvey M, Slangle BL, McArthur M, Montgomery CA, Butel JS, et al: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 1992;356:215-21 https://doi.org/10.1038/356215a0
  4. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 1991;351:453-456 https://doi.org/10.1038/351453a0
  5. Irwin MS, Kaelin WG Jr: Role of the newer p53 family proteins in malignancy. Apoptosis 2001;6:17-29 https://doi.org/10.1023/A:1009663809458
  6. Nylander K, Dabelsteen E, Hall PA: The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 2000;29:413-25 https://doi.org/10.1034/j.1600-0714.2000.290901.x
  7. Prives C, Hall PA: The p53 pathway. J Pathol 1999;187:112-26 https://doi.org/10.1002/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3
  8. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 1991;253:49-53 https://doi.org/10.1126/science.1905840
  9. Ahomadegbe C, Barrois M, Fogel S, Le Bihan ML, Douc-Rasy S, Duvillard P, et al: High incidence of p53 alterations (mutation, deletion, overexpression) on head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early noninvasive lesions. Oncogene 1995;10:4855-78
  10. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenes-is. Cancer Res 1994;54:485-578
  11. Ness M, Homann N, Discher H, Andl T, et al: Expression of mutated p53 occurs in tumor distant epithelia of head and neck cancers patients: A possible molecular basis for development of multiple tumors. Cancer Res 1993;53:4189-96
  12. Yang A, Kagdah M, Wang Y, et al: p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2:305-316 https://doi.org/10.1016/S1097-2765(00)80275-0
  13. Kaelin WG: The p53 gene family. Oncogene 1999;18:7701-7705 https://doi.org/10.1038/sj.onc.1202955
  14. Trink B, Okami K, Wu L, et al: A new human p53 homologue. Nat Med 1998;4:747-748 https://doi.org/10.1038/nm0798-747
  15. Osada M, Ohba M, Kawahara C, et al: Cloning and functional analysis of human p51, which structurally and functionally resembles p35. Nat Med 1998;4:839-843 https://doi.org/10.1038/nm0798-839
  16. Senoo M, Seki N, Ohira M, et al: A second p53-related protein, p73L, with high homology to p73. Biochem Biophys Res Commun 1998; 30:603-607
  17. Marin MC, Kaelin WG Jr: p63 and p73: Old members of a new family. Biochem Biophys Acta 2000;1470:M93-M100
  18. A. Yang, M. Kaghad, Y. Wang, E. Gillett, M.D. Fleming, V: D¨otsch, N.C. et al. p63, a p53 homolog at 3q27-29 encodes multiple products with transactivating, death-inducing, and dominant negative activities. Mol Cell 1998;2:305-316 https://doi.org/10.1016/S1097-2765(00)80275-0
  19. K.M. Liefer, M.I. Koster, X.J. Wang, A. Yang, F. McKeon, D.R. Roop. Down-regulation of p63 is required for epidermal UV-Binduced apoptosis, Cancer Res 2000;60:4016-4020
  20. A. Yang, F. McKeon. P63 and p73: p53 mimics, menaces and more. Nat Rev Mol Cell Biol 2000;1:199-207 https://doi.org/10.1038/35043127
  21. K. Hibi, B. Trink, M. Patturajan, W.H. Westra, O.L. Caballero, D.E. et al. AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 2000;97:5462-5467
  22. A. Yang, R. Schweitzer, D. Sun, M. Kaghad, N. Walker, R.T. Bronson, C. Tabin, et al: p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999; 398:714-718 https://doi.org/10.1038/19539
  23. Tsujita-Kyutoku M, Kiuchi K, Danbara N, Yuri T, Senzaki H, et al. p63 expression in normal human epidermis and epidermal appendages and their tumors. J Cut Pathol 2003;30:11-7 https://doi.org/10.1034/j.1600-0560.2003.300102.x
  24. Mills AA, Zheng B, Wang X-J, Vogel H, Roop DR, Bradley A: p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999;398:708-13 https://doi.org/10.1038/19531
  25. Donehower LA, Bradley A: The tumor suppressor p53. Biochim Biophys Acta 1993;1155:181-205
  26. Choi HR, Batsakis JG, Zhan F, Sturgis E, Luna MA, El-Naggar AK: Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Hum Pathol 2002; 33:158- 164 https://doi.org/10.1053/hupa.2002.30722
  27. Crook T, Nicholls JM, Brooks L, O''Nions J, Allday MJ: High level expression of MNp63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC). Oncogene 2000; 19:439-3444
  28. Davison TS, Vagner C, Kaghad M, Ayed A, Caput D, Arrowsmith CH: p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53. J Biol Chem 1999; 274:18709-18714 https://doi.org/10.1074/jbc.274.26.18709
  29. Strano S, Rossi M, Fontemaggi G, Munarriz E, Soddu S, Sacchi A, Blandino G: From p63 to p53 across p73. FEBS Lett 2001;490:163-170 https://doi.org/10.1016/S0014-5793(01)02119-6
  30. Augustin M, Bamberger C, Paul D, Schmae H: Cloning and chromosomal mapping of the human p53-related KET gene to chromosome 3q27 and its murine homolog Ket to mouse chromosome 16. Mamm Genome 1998;9:899-902 https://doi.org/10.1007/s003359900891
  31. Osada M, Ohba M, Kawahara C, Ishioka C, Kanamaru R, et al: Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med 1998;4:839-843 https://doi.org/10.1038/nm0798-839
  32. Davison TS, Vagner C, Kaghad M, Ayed A, Caput D, Arrowsmith CH: p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53. J Biol Chem 1999;274:18709-18714 https://doi.org/10.1074/jbc.274.26.18709
  33. Faridoni-Laurens L, Bosq J, Janot F, Vayssade M, et al: p73 expression in basal layers of head and neck squamous cell epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63? Oncogene 2001;20:5302-5312 https://doi.org/10.1038/sj.onc.1204687
  34. Nylander K, Coates PJ, Hall PA: Characterization of the expression pattern of p63$\alpha$and $\delta$Np63a in benign and malignant oral epithelial lesions. Int J Cancer 2000;87:368-372 https://doi.org/10.1002/1097-0215(20000801)87:3<368::AID-IJC9>3.0.CO;2-J
  35. Weber A, Bellmann U, Bootz F, Wittekind C, Tannapfel A: Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck. Int J Cancer 2002;99:22-28 https://doi.org/10.1002/ijc.10296
  36. Nylander K, Vojtesek B, Nenutil R, Lindgren B, Roos G, et al: Differential expression of p63 isoforms in normal tissues and neoplastic cells. J Pathol 2002;198:417-427 https://doi.org/10.1002/path.1231
  37. Parsa R, Yang A, McKeon F, Green H: Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol 1999;113:1099-1105 https://doi.org/10.1046/j.1523-1747.1999.00780.x
  38. Pellegrini G, Dellambra E, Golisano O, et al: p63 identifies keratinocyte stem cells. Proc Natl Acad Sci U S A 2001;13:3156-3161
  39. OConnell JT, Mutter GL, Cviko A, et al: Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63. Gynecol Oncol 2001;80:30-36 https://doi.org/10.1006/gyno.2000.6026
  40. Quade BJ, Yang A, Wang Y, et al: Expression of the p53 homologue p63 in early cervical neoplasia. Gynecol Oncol 2001;80:24-29 https://doi.org/10.1006/gyno.2000.5953
  41. Signoretti S, Waltgreny D, Dilks J, et al: p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol 2000;157:1769-1775 https://doi.org/10.1016/S0002-9440(10)64814-6
  42. Senoo M, Tsuchiya I, Matsumura Y, et al: Transcriptional dysregulation of the p73L/p63/p51/p40/KET gene in human squamous cell carcinomas: expression of $\delta$Np73L, a novel dominantnegative isoform, and loss of expression of the potential tumour suppressor p51. Br J Cancer 2001;84:1235-1241 https://doi.org/10.1054/bjoc.2000.1735
  43. Barbareschi M, Pecciarini L, Cangi MG, et al: p63, a p53 homologue, is a selective marker of myoepithelial cells of the human breast. Am J Surg Pathol 2001;25:1054-1060 https://doi.org/10.1097/00000478-200108000-00010
  44. Hall PA, Campbell SJ, O''Neill M, et al: The expression of the p53 homologue, p63$\alpha$and Np63$\alpha$in normal and neoplastic cells. Carcinogenesis 2000;21:153-160 https://doi.org/10.1093/carcin/21.2.153
  45. Tannapfel A, Schmelzer S, Benicke M, et al: Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer. J Pathol 2001;195:163-170 https://doi.org/10.1002/path.947
  46. Di Como CJ, Urist MJ, Babayan I, et al: p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002;8:494-501
  47. Hall PA, Woodman AC, Campbell SJ, Shepherd NA: Expression of the p53 homologue p63$\alpha$and Np63$\alpha$in the neoplastic sequence of Barrett'oesophagus: correlation with morphology and p53 protein. Gut 2001;49:618-23 https://doi.org/10.1136/gut.49.5.618
  48. Faridoni-Laurens L, Bosq J, Janot F, et al: P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63? Oncogene 2001;20: 5302-5312 https://doi.org/10.1038/sj.onc.1204687